SHPH Q3 2025 Earnings — Shuttle Pharmaceuticals Holdings, Inc. Revenue & Financial Results | Market Cap Arena

SHPHShuttle Pharmaceuticals Holdings, Inc.

$1M

Q3 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

-$1,008

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-1.05

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$134,318

Balance Sheet

Total Assets

$4M

Total Liabilities

$2M

Stockholders' Equity

$1M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1,008	$0	—
Operating Income	-$2M	-$3M	+25.7%
Net Income	-$2M	-$4M	+38.0%